Last edition
News about "Sun Pharma three diabetes drug brands in India fro"
Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca
Sun Pharmaceutical Industries Ltd has acquired the rights to trademarks of diabetes drug dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, the parent company of AstraZeneca Pharma India
Sun Pharma Three Diabetes Drug Brands In India Fro | 30/05/2021 | By Darshana | 300
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members